Comparative Acceptability and Perceived Clinical Utility of Monitoring Tools

Agreement Between Rectosigmoidoscopy and Colonoscopy Analyses of Disease Activity and Healing in Patients With Ulcerative Colitis

(2016) Jean-Frédéric Colombel et al.   GASTROENTEROLOGY

Bowel Ultrasonography in the Management of Crohnʼs Disease. A Review with Recommendations of an International Panel of Experts

(2016) Emma Calabrese et al.   INFLAMMATORY BOWEL DISEASES

Magnetic resonance enterography or video capsule endoscopy – what do Crohn’s disease patients prefer?

(2016) Adi Lahat et al.   Patient Preference and Adherence

Consecutive monitoring of faecal calprotectin during mesalazine suppository therapy for active rectal inflammation in ulcerative colitis

(2015) T. Yamamoto et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Diffusion-weighted magnetic resonance imaging is effective to detect ileocolonic ulcerations in Crohn's disease

(2015) A. Buisson et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

C-Reactive Protein, Fecal Calprotectin and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis

(2015) Mahmoud H Mosli et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target

(2015) L Peyrin-Biroulet et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Treat to Target: A Proposed New Paradigm for the Management of Crohn's Disease

(2015) Guillaume Bouguen et al.   Clinical Gastroenterology and Hepatology

Endoscopic Factors Influencing Fecal Calprotectin Value in Crohn’s Disease

(2015) F. Goutorbe et al.   Journal of Crohns & Colitis

Fecal calprotectin: towards a standardized use for inflammatory bowel disease management in routine practice.

(2015) E. Louis   Journal of Crohns & Colitis

Low Fecal Calprotectin Predicts Sustained Clinical Remission in Inflammatory Bowel Disease Patients: A Plea for Deep Remission

(2014) Erik Mooiweer et al.   Journal of Crohns & Colitis

Diffusion-weighted magnetic resonance imaging for detecting and assessing ileal inflammation in Crohn's disease

(2013) A. Buisson et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Diffusion-Weighted Magnetic Resonance Imaging in Ileocolonic Crohn's Disease: Validation of Quantitative Index of Activity

(2013) C Hordonneau et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Endoscopic Assessment and Treating to Target Increase the Likelihood of Mucosal Healing in Patients With Crohn’s Disease

(2013) Guillaume Bouguen et al.   Clinical Gastroenterology and Hepatology

Colonoscopic perforations in inflammatory bowel disease: A retrospective study in a French referral centre

(2013) Anthony Buisson et al.   DIGESTIVE AND LIVER DISEASE

Recommendations Endoscopy in inflammatory bowel disease: recommendations from the IBD Committee of the French Society of Digestive Endoscopy (SFED)

(2013) Laurent Peyrin-Biroulet et al.   ENDOSCOPY

Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines

(2013) J. Panes et al.   Journal of Crohns & Colitis

Aluminum enhances inflammation and decreases mucosal healing in experimental colitis in mice

(2013) G Pineton de Chambrun et al.   Mucosal Immunology

C-reactive protein, an indicator for maintained response or remission to infliximab in patients with Crohn's disease: a post-hoc analysis from ACCENT I

(2012) W. Reinisch et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Patient experiences of MR colonography and colonoscopy: a qualitative study

(2012) R Hafeez et al.   BRITISH JOURNAL OF RADIOLOGY

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

(2012) Geert DʼHaens et al.   INFLAMMATORY BOWEL DISEASES

Patient burden and patient preference: Comparing magnetic resonance enteroclysis, capsule endoscopy and balloon-assisted enteroscopy

(2012) Bart M Wiarda et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Mucosal healing—EXTENDing our knowledge in Crohn's disease

(2012) Silvio Danese et al.   Nature Reviews Gastroenterology & Hepatology

Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn’s disease

(2011) L. S. Kiss et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health

(2011) Laurent Peyrin-Biroulet et al.   GUT

Results from the 2nd Scientific Workshop of the ECCO (I): Impact of mucosal healing on the course of inflammatory bowel disease

(2011) Laurent Peyrin-Biroulet et al.   Journal of Crohns & Colitis

Fecal calprotectin is equally sensitive in Crohn's disease affecting the small bowel and colon

(2011) Michael Dam Jensen et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Diagnostic Accuracy of Capsule Endoscopy for Small Bowel Crohn's Disease Is Superior to That of MR Enterography or CT Enterography

(2010) Michael Dam Jensen et al.   Clinical Gastroenterology and Hepatology

Magnetic resonance imaging for evaluation of Crohnʼs disease

(2010) Jordi Rimola et al.   INFLAMMATORY BOWEL DISEASES

Fecal Calprotectin Correlates More Closely With the Simple Endoscopic Score for Crohn's Disease (SES-CD) than CRP, Blood Leukocytes and the CDAI

(2009) Alain M Schoepfer et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease

(2009) Filip Baert et al.   GASTROENTEROLOGY

Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease

(2009) J. Rimola et al.   GUT

Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohnʼs disease

(2009) Fabian Schnitzler et al.   INFLAMMATORY BOWEL DISEASES

Disability in inflammatory bowel diseases: Developing ICF core sets for patients with inflammatory bowel diseases based on the international classification of functioning, disability, and health

(2009) Laurent Peyrin-Biroulet et al.   INFLAMMATORY BOWEL DISEASES

Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn’s disease and histological findings

(2008) T. SIPPONEN et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Noninvasive Markers in the Assessment of Intestinal Inflammation in Inflammatory Bowel Diseases: Performance of Fecal Lactoferrin, Calprotectin, and PMN-Elastase, CRP, and Clinical Indices

(2007) Jost Langhorst et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Crohnʼs disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohnʼs disease activity index and endoscopic findings

(2007) Taina Sipponen et al.   INFLAMMATORY BOWEL DISEASES